• Sat. Nov 19th, 2022

010 LKKJ

Learn today, build tomorrow

Amgen Revenues and Revenue Growth from 2012 to 2016

Byadmin

Nov 7, 2022
Amgen Revenues

This report shows the revenue growth and revenues for Amgen Inc (AMGN) over the five years from 2012 to 2016. Amgen’s total 2016 revenues were $23 billion. Amgen saw a 6.1% increase in revenue year-over-year in 2016. The fiscal year ending in December is reflected in the revenues and revenue growth.

AMGEN REVENUES 2012-2016

These are Amgen’s revenues and growth details for the past five years.

In 2012, Amgen generated $17.3 trillion in revenues. Amgen saw a 10.8% increase in revenues year-over-year in 2012.

Amgen’s total $18.7 Billion revenues in 2013 were $18.7 billion. Amgen saw an 8.2% increase in revenues year-over-year in 2013.

In 2014, Amgen generated $20.1 trillion in revenues. Amgen saw a 7.4% increase in revenues year-over-year in 2014.

In 2015, Amgen generated $21.7 trillion in revenues. Amgen saw an 8% increase in revenues year-over-year in 2015.

In 2016, Amgen’s total revenues were $23 Billion. Amgen saw a 6.1% increase in revenues year-over-year in 2016.

WHY ANALYZE REVENUE GROWTH?

The most common financial metric is revenue growth. Revenue growth is the percentage increase or decrease in revenue for a company between two periods. The formula is used to calculate it: (revenues during period two – revenue during period one)/ revenues during period one)*100. The revenue growth year-over-year is calculated if the periods are consecutive. If the periods are two consecutive quarters, the revenue growth is referred to as the quarterly revenue growth quarter-over-quarter. Revenue growth refers to quarterly revenue growth year over year if the time periods are the same quarter in both consecutive years. If the periods are not consecutive, the revenue CAGR (Commutative Annual Growth Rate) is calculated.
caranddriving.net
fbkerch.org
canadagoosejacketsoutlet.net
thefreeauction.net
citizen-k-blog.com

For many reasons, revenue growth analysis is very important. It helps to understand how a company is performing. Favorable revenue growth rates indicate that the business is doing well and revenues are rising. If they are negative, it is a sign that revenues are falling, and the company must take steps to increase them. The company will shrink if they don’t. A company’s past revenue growth analysis, market size, and market share analysis can be used to forecast future revenues. Third, it is possible to compare a company’s growth rate with its competitors. This helps determine who is winning more business. Market share increases when revenue growth is higher than the industry average. High revenue growth rates are the best indicators of industry disruption.

AMGEN RANGING

Amgen was ranked number 119 with $23 billion in revenues in 2016. Every one of the top 3000 companies earned more than $50,000,000 in annual revenue during 2016.

These were the top 20 US companies by revenue in 2016.

Walmart ($482.1 million)

ExxonMobil ($226.1 million)

Berkshire Hathaway ($223.6 million)

Apple ($215.6 Billion)

McKesson (190.9 billion)

UnitedHealth Group ($184.8 million)

CVS Health ($177.5 million)

General Motors ($166.4 Billion)

AT&T ($163.8 billion)

Ford Motor (£151.8 billion).

AmerisourceBergen ($146.8 billion)

Amazon ($136 billion).

Verizon ($126 billion).

General Electric (123.7 billion)

Cardinal Health ($121.5 million)

Costco ($118.7 billion)

Walgreens Boots Alliance ($117.4 Billion)

Chevron ($114.5 billion)

Kroger ($109.8 Billion)

Express Scripts Holding ($100.3 Billion)

R&P Research assigns each company to one sector and one business industry to benchmark their performance. An industry is a group of businesses with similar business models. A sector is a collection of similar/related industries. To facilitate high-level analysis, similar sectors are divided into sector groups.

The Healthcare sector includes, for example, the Life Sciences and Services sectors. The Life Sciences sector includes the following industries: Pharmaceuticals, Medical Devices, Biotechnology, Diagnostics & Scientific Instruments. Healthcare Services include the following industries: Medication Stores and PBM and Distributors; Healthcare Payers, Healthcare Providers; Medical Software Services; Healthcare Research Services.

Amgen is associated with the Healthcare Sector Group and Life Sciences Sector.

Amgen was ranked 21 of all US Healthcare sector companies with $23 billion in revenues. In 2016, there were 290 US Healthcare sector companies with revenues exceeding $50 million.

These were the top 10 companies in the US Healthcare industry group by revenue in 2016.

McKesson (190.9 billion)

UnitedHealth Group ($184.8 million)

CVS Health ($177.5 million)

AmerisourceBergen ($146.8 billion)

Cardinal Health ($121.5 million)

Walgreens Boots Alliance ($117.4 Billion)

Express Scripts Holding ($100.3 Billion)

Anthem (84.9 billion USD)

J&J ($71.9 billion)

Aetna ($63.2 million)

The Healthcare sector group includes the following sectors: Life Sciences and Healthcare Services.

Amgen was ranked 7thout of all US Life Sciences sector companies with $23 billion in revenues. In 2016, 197 US Life Sciences companies generated more than $50 million in revenue.

These were the top 10 US Life Sciences companies by revenue in 2016.

J&J ($71.9 billion)

Pfizer ($52.8 Billion)

Merck ($39.8 Billion)

Gilead Sciences ($30.4 Billion)

Medtronic ($28.8 Billion)

Abbvie ($25.6 billion)

Amgen ($23 billion)

Eli Lilly ($21.2 Billion)

Abbott Laboratories ($20.9 billion)

Bristol Myers Squibb (19.4 Billion)

The Life Sciences sector includes the following industries: Pharmaceuticals, Medical Devices, Biotechnology, Diagnostics & Scientific Instruments. These are the definitions of each industry:

The pharmaceutical industry is comprised of companies that develop, manufacture, and market medications. These companies generally offer prescription and over-the-counter pharmaceutical products. Many pharmaceutical companies offer a wide range of services, products, and solutions for animal health. Diverse pharmaceutical companies can operate in multiple segments, including consumer health products and medical devices.

The Medical Equipments industry comprises manufacturers and distributors of medical equipment. Large-scale capital equipment such as X-ray machines, MRI scanners, and another non-disposable medical devices like pacemakers and stents are all medical equipment. Manufacturers of disposable medical supplies, such as contact lenses, eyeglass lenses, and bandages, include Medical Supplies.

The Biotechnology Industry comprises Biotechnology product companies, subscription companies, and service companies. Biotechnology products sell pharmaceutical medications made from, extracted from, semi-synthesized, or partially synthesized in biological sources. Companies that subscribe to the service model create genome databases that can be used for developing medicinal drugs. Services companies provide solutions that are based on the same technology or generic tool used by large pharmaceutical and biopharmaceutical corporations.

Diagnostics & Scientific Instruments is a category that includes companies that offer diagnostic reagents, instruments, and testing products to help diagnose and treat various diseases. This includes companies that produce, market, and sell diagnostic tests, diagnostic systems, and related products and services. Companies that produce and market diagnostic instruments, equipment, consumables, and reagents for research, manufacturing, and analysis are also included.

Amgen was ranked #3 with $23 billion in revenues. In 2016, 45 companies reported revenues exceeding $50 million in the US Biotechnology sector.

These were the top 10 US companies in the US biotechnology industry by revenue in 2016.

Gilead Sciences ($30.4 Billion)

Abbvie ($25.6 billion)

Amgen ($23 billion)

Biogen ($11.4 billion)

Celgene ($11.2 billion)

Regeneron ($4.9 billion)

Alexion Pharmaceuticals ($3.1 million)

Vertex Pharmaceuticals ($1.7 billion)

United Therapeutics ($1.6 Billion)

BioMarin Pharmaceutical ($1.1 Billion)

COMPANIES – SEGMENTATION

R&P Research divides companies into segments based on revenues, revenue growth, and net profit margins. This allows them to identify and analyze companies with high/low growth and the most/least profitable companies of similar size in different industries or sectors.

The following four segments are based on the company’s annual revenue:

Mega companies with revenues exceeding $50 billion

Companies with revenues between $10 billion to $50 billion are considered very large.

Large companies with revenues between $1 billion to $10 billion

Companies of mid-size with revenues between $50 Million and $1 Billion

Amgen had $23 billion in revenues in 2016. There were 239 companies in this Very Large Companies revenue segment in 2016.

The following eight segments are based on the company’s annual revenue growth:

Companies with a very high positive growth rate have more than 50% annual revenue growth.

Companies with high positive growth, with annual revenue growth of between 20% and 50%

Companies with medium positive growth have annual revenue growth of between 5% and 20%.

Companies with low positive growth, with annual revenue growth of between 0% to 5%

Companies with low negative growth have annual revenue growth of -5% to 0%.

Companies with medium negative growth have annual revenue growth of -20% to -5%.

Companies with high negative growth have annual revenue growth of between -50% to -20%.

Companies with very high negative growth have annual revenue growth of less than -50%.

Amgen saw a 6.1% growth in revenue year-over-year during 2016. Eight hundred seventy-six companies were in the Medium negative revenue growth segment in 2016. The top 3000 US companies had positive revenue growth in 2016, with 85 (nearly a third) and 1015 (100%) having negative revenue growth.

The companies are classified based on their annual net profit margin.

Companies with a very high positive margin, with a net profit margin of more than 50%.

Companies with high positive margins, which have a net profit margin between 20% to 50%

Companies with medium positive margins, have a net profit margin between 5 and 20 percent.

Companies with a low positive margin have a net profit margin between 0% and 5%.

Companies with low negative margins have a net profit margin between 5 and 0%.

Companies with medium negative margins, with net profit margins between -20% to -5%.

Companies with high negative margins, with net profit margins between -50% to -20%.

Companies with very high negative margins, with a net profit margin of less than -50%.

Amgen was in a High positive net margin segment with a net margin of 33.6% in 2016. In 2016, there were 397 companies in the High positive net margin segment. The top-three-quarters of the US’s top 300 companies had a positive net profit margin, with 2244 being close to three-quarters of them. 756 was almost one-fourth and had a negative net profit margin in 2016.

COMPANY’S BUSINESS SUMMARY

Amgen Inc. develops, manufactures, and delivers therapeutics for humans worldwide. It provides products to treat illnesses such as oncology/hematology and cardiovascular disease, inflammation, bone health, neurology, and nephrology.

The evening is used to treat osteoporosis in postmenopausal females; Prolia is used to treat women with osteoporosis postmenopausal; Xgeva to prevent skeletal-related events; Repatha to manage coronary artery disease; Enbrel to treat plaque psoriasis and rheumatoid and psoriatic joint diseases; Parsabiv is used to treat secondary hyperparathyroidism, and Erenumab to prevent migraine.

Blincyto treats Philadelphia chromosome -negative relapsed or refractory B cell precursor acute lymphoblastic Leukemia. Kyprolis is used to treat multiple myeloma. Nplate is used to treat thrombopoietin compounds. ABP 215 can be used to screen biosimilar candidates. ABP 980 treats early-stage human epidermal growth factors receptor 2-positive breast cancer.

The company’s other marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat short in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells.

It is available to pharmaceutical wholesale distributors, doctors, clinics, dialysis centers, pharmacies, and consumers. Pfizer Inc., UCB, Bayer HealthCare Pharmaceuticals Inc., Array BioPharma Inc., and Syngene International Limited have collaborated with the company.

Amgen Inc. was established in 1980. Its headquarters are located in Thousand Oaks (California).

DATASTORE

This page’s chart and data are from the R&P Research Industry Intelligence Platform. This platform gives the financial metrics for all public companies in the United States. Users can compare the financial data for a company’s last five to 15 years with other companies and industry averages. This benchmarking exercise can provide powerful insights to help you make better business decisions.